A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate to Severe Refractory Autoimmune Diseases
Clinical trial NCT07614191 · RECRUITING
Trial details
- NCT number
- NCT07614191
- Sponsor
- Vivacta Biotechnology (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-25
- Primary completion
- 2031-12-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.